63 results on '"Krenning, Eric"'
Search Results
2. 99mTc-labeled gastrins of varying peptide chain length: Distinct impact of NEP/ACE-inhibition on stability and tumor uptake in mice
3. Radiolabeled Somatostatin Analogue Therapy Of Gastroenteropancreatic Cancer
4. Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors
5. In vivo inhibition of neutral endopeptidase enhances the diagnostic potential of truncated gastrin 111In-radioligands
6. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
7. [DOTA]Somatostatin-14 analogs and their 111In-radioligands: Effects of decreasing ring-size on sst1–5 profile, stability and tumor targeting
8. Peptide receptor radionuclide therapy (PRRT) for GEP-NETs
9. Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides
10. Somatostatin Receptor-Targeted Radionuclide Therapy in Patients with Gastroenteropancreatic Neuroendocrine Tumors
11. 68Ga-labeled DOTA-Peptides and 68Ga-labeled Radiopharmaceuticals for Positron Emission Tomography: Current Status of Research, Clinical Applications, and Future Perspectives
12. Role of Somatostatins in Gastroenteropancreatic Neuroendocrine Tumor Development and Therapy
13. Preclinical and Clinical Studies of Peptide Receptor Radionuclide Therapy
14. Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors
15. Gastroenteropancreatic neuroendocrine tumours
16. The kinetics of thyroid hormone transporters and their role in non-thyroidal illness and starvation
17. Peptide receptor radionuclide therapy
18. Dose-dependent effects of (anti)folate preinjection on 99mTc-radiofolate uptake in tumors and kidneys
19. Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and CCK analogues: species and gender differences
20. Treatment of Patients Who Have Endocrine Gastroenteropancreatic Tumors with Radiolabeled Somatostatin Analogues
21. Staging and treatment of differentiated thyroid carcinoma with radiolabeled somatostatin analogs
22. Prognostic Implications of a Normal Stress Technetium-99m–Tetrofosmin Myocardial Perfusion Study in Patients With a Healed Myocardial Infarct and/or Previous Coronary Revascularization
23. Survival and Response After Peptide Receptor Radionuclide Therapy With [ 90Y-DOTA 0,Tyr 3]Octreotide in Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors
24. Peptide receptor radionuclide therapy
25. O-26 - Metabolic stability and tumor uptake improvements via an ABD-arm in [99mTc]Tc-DT10: first preclinical experiences in pancreatic cancer models
26. Long-term prognostic value of dobutamine stress echocardiography compared with myocardial perfusion scanning in patients unable to perform exercise tests
27. Preoperative comparison of different noninvasive strategies for predicting improvement in left ventricular function after coronary artery bypass grafting
28. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia
29. Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings
30. Phase I study of peptide receptor radionuclide therapy with [ 111In-DTPA 0]octreotide: The rotterdam experience
31. Somatostatin receptor imaging
32. Safety, Hemodynamic Profile, and Feasibility of Dobutamine Stress Technetium Myocardial Perfusion Single-Photon Emission CT Imaging for Evaluation of Coronary Artery Disease in the Elderly
33. Accuracy of exercise stress technetium 99m sestamibi SPECT imaging in the evaluation of the extent and location of coronary artery disease in patients with an earlier myocardial infarction
34. Accuracy of dobutamine tetrofosmin myocardial perfusion imaging for the noninvasive diagnosis of transplant coronary artery stenosis
35. Therapeutic use of radiolabelled peptides
36. Identification of Thyroid Hormone Transporters
37. Dobutamine stress echocardiography and technetium-99m-tetrofosmin/fluorine 18-fluorodeoxyglucose single-photon emission computed tomography and influence of resting ejection fraction to assess myocardial viability in patients with severe left ventricular dysfunction and healed myocardial infarction
38. 761 Circulating Neuroendocrine Gene Transcripts Accurately Identify GEP-NETs, Are Decreased by Surgery and Predict Tumor Progression and Recurrence
39. Reduction of skeletal accumulation of radioactivity by co-injection of DTPA in [ 90Y-DOTA 0,Tyr 3]octreotide solutions containing free 90Y 3+
40. Relation between QT dispersion and myocardial viability in ischemic cardiomyopathy
41. [( 111In-DOTA)Lys 0]Tate: effects of Lys 0-Introduction on AR4-2J tumor and kidney uptake in SCID mice
42. Biodistribution of [ 111In-DOTA 0,trp 8]SS-14 in sst 2/3/5+-HEK tumor-bearing mice
43. Comparison of [ 111In]SAR-G2 and 3 in GRPR + cells and animal models
44. Anaphylactoid reaction from amifostine
45. Comparison of dobutamine stress echocardiography and 201thallium SPECT in the evaluation of the extent of coronary artery disease after myocardial infarction
46. Clinical applications of somatostatin analogs
47. Effects of ligand priming and multiple-dose injection on tissue uptake of 111In-pentetreotide in rats
48. 99mTc-MIBI, 99mTc-Tetrofosmin and 99mTc-Q12 In Vitro and In Vivo
49. 2 The clinical use of somatostatin analogues in the treatment of cancer
50. Somatostatin Analogs in the Treatment of Acromegaly
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.